Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors

Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors

Members of the MYC family are the most frequently deregulated oncogenes in human cancer and are often correlated with aggressive disease and/or poorly differentiated tumors. Since patients with MYCN-amplified neuroblastoma have a poor prognosis, targeting MYCN using small molecule inhibitors could r...

Full description

Bibliographic Details
Main Authors:	Müller, Inga, Larsson, Karin, Frenzel, Anna, Oliynyk, Ganna, Zirath, Hanna, Prochownik, Edward V., Westwood, Nicholas J., Henriksson, Marie Arsenian
Format:	Online
Language:	English
Published:	Public Library of Science 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032254/

Similar Items

Identification of Cytotoxic Drugs That Selectively Target Tumor Cells with MYC Overexpression
by: Frenzel, Anna, et al.
Published: (2011)

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
by: Wang, Huabo, et al.
Published: (2015)

Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin
by: WANG, STEPHANIE S., et al.
Published: (2014)

MYC proteins promote neuronal differentiation by controlling the mode of progenitor cell division
by: Zinin, Nikolay, et al.
Published: (2014)

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study
by: Wang, L L, et al.
Published: (2015)

MYCN and the epigenome
by: He, Stanley, et al.
Published: (2013)

Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion
by: Wang, Huabo, et al.
Published: (2015)

MycPermCheck: the Mycobacterium tuberculosis permeability prediction tool for small molecules
by: Merget, Benjamin, et al.
Published: (2013)

MycN Is Critical for the Maintenance of Human Embryonic Stem Cell-Derived Neural Crest Stem Cells
by: Zhang, Jie Ting, et al.
Published: (2016)

MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines
by: Lange, Ingo, et al.
Published: (2014)

Correction: MycN Is Critical for the Maintenance of Human Embryonic Stem Cell-Derived Neural Crest Stem Cells
by: Zhang, Jie Ting, et al.
Published: (2016)

Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
by: Wang, Huabo, et al.
Published: (2013)

Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase
by: Peter, Stefanie, et al.
Published: (2014)

Dangerous liaisons: MYCN meets condensins
by: Achar, Yathish Jagadheesh, et al.
Published: (2014)

Editorial: Targeting MYCN in Pediatric Cancers
by: Sala, Arturo
Published: (2015)

Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression
by: Felsenstein, Kenneth M., et al.
Published: (2015)

Exploitation of chick embryo environments to reprogram MYCN-amplified neuroblastoma cells to a benign phenotype, lacking detectable MYCN expression
by: Carter, R, et al.
Published: (2012)

MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation
by: Beckers, Anneleen, et al.
Published: (2014)

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
by: Chen, Bing-Jia, et al.
Published: (2014)

Reversible Linkage of Two Distinct Small Molecule Inhibitors of Myc Generates a Dimeric Inhibitor with Improved Potency That Is Active in Myc Over-Expressing Cancer Cell Lines
by: Wanner, Jutta, et al.
Published: (2015)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
by: Holien, Toril, et al.
Published: (2015)

S(+)-ibuprofen destabilizes MYC/MYCN and AKT, increases p53 expression, and induces unfolded protein response and favorable phenotype in neuroblastoma cell lines
by: IKEGAKI, NAOHIKO, et al.
Published: (2013)

Regulation of MYCN expression in human neuroblastoma cells
by: Jacobs, Joannes FM, et al.
Published: (2009)

MYCN and mutationally activated ALK synergise in neuroblastoma
Published: (2012)

MYCN: from oncoprotein to tumor-associated antigen
by: Pistoia, Vito, et al.
Published: (2012)

On the significance of germline cytogenetic rearrangements at MYCN locus in neuroblastoma
by: Lipska, Beata S, et al.
Published: (2013)

Multiple mechanisms of MYCN dysregulation in Wilms tumour
by: Williams, Richard D., et al.
Published: (2015)

Mitochondrial Structure, Function and Dynamics Are Temporally Controlled by c-Myc
by: Graves, J. Anthony, et al.
Published: (2012)

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
by: Buechner, J, et al.
Published: (2011)

Molecular mechanisms of MYCN-dependent apoptosis and the MDM2–p53 pathway: an Achille’s heel to be exploited for the therapy of MYCN-amplified neuroblastoma
by: Petroni, Marialaura, et al.
Published: (2012)

microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13
by: Han, Han, et al.
Published: (2016)

Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor
by: Yoshimura, Yayoi, et al.
Published: (2015)

A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma
by: Sottile, Francesco, et al.
Published: (2012)

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
by: Guan, J., et al.
Published: (2016)

Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
by: Wang, Jing, et al.
Published: (2014)

MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
by: Lodrini, Marco, et al.
Published: (2013)

Origins of Myc Proteins – Using Intrinsic Protein Disorder to Trace Distant Relatives
by: Mahani, Amir, et al.
Published: (2013)

Small Molecule Inhibitors of CXCR4
by: Debnath, Bikash, et al.
Published: (2013)

Small Molecule Deubiquitinase Inhibitors Promote Macrophage Anti-Infective Capacity
by: Charbonneau, Marie-Eve, et al.
Published: (2014)

ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma
by: Hasan, Md. Kamrul, et al.
Published: (2013)